image credit: Unsplash

COVID-19 tracker: FDA advisory group will discuss Merck antiviral; Companies test vaccines against new variant

November 29, 2021


Companies are testing their COVID-19 vaccines against the new variant, omicron.

An FDA advisory committee will meet tomorrow to discuss its recommendation for Merck’s COVID-19 antiviral.

The worldwide case count stood at more than 261.98 million Monday afternoon, with more than 5.2 million reported deaths, according to Johns Hopkins University’s COVID-19 dashboard.

Please read below for the latest updates. Daily COVID-19 tracker entries from April 29 to Nov. 29 can be found here. Daily entries from Nov. 2, 2020, to April 28 can be found here.

Read More on FiercePharma